Skip to main content
OpenTrials

Clinical trial condition

Melanoma

Explore clinical trials studying Melanoma. Study availability and eligibility vary by location and protocol.

2,207 public trials 376 recruiting studies
Refine in advanced search Browse all conditions

Melanoma trial results

Active, Not Recruiting

A Clinical Study of BCD-217 (Nurulimab + Prolgolimab) Followed by Anti-PD-1 Compared to Anti-PD-1 Monotherapy as First-Line Treatment in Subjects With Unresectable/Metastatic Melanoma

NCT05732805

Conditions
Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Melanoma (Skin), +16 more
Locations
  • Healthcare Institution "Bobruisk Interdistrict Oncological Dispensary" Babruysk, Belarus
  • Healthcare Institution "Brest Regional Oncological Dispensary" Brest, Belarus
  • Health care institution "Grodno University Clinic" Grodno, Belarus
  • Health Institution "Gomel Regional Clinical Oncology Center" Homyel, Belarus
View all 63 locations
View Trial Details
Active, Not Recruiting

Neoadjuvant PD-1 Blockade in Patients with Stage IIB/C Melanoma

NCT03757689

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • University of Louisville Louisville, Kentucky, United States
  • Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
View Trial Details
Active, Not Recruiting

Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers

NCT03212404

Conditions
Adenocarcinoma, Adenoma, Bronchial Neoplasms, +67 more
Locations
  • Research Site Wollongong, New South Wales, Australia
  • Research Site Benowa, Queensland, Australia
  • Research Site Buderim, Queensland, Australia
  • Research Site Greenslopes, Queensland, Australia
View all 48 locations
View Trial Details
Active, Not Recruiting

Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With CRC, NSCLC, and STS

NCT05688280

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +36 more
Locations
  • Miami Cardiac & Vascular Institute Coral Gables, Florida, United States
  • University of Louisville Physicians, PSC Louisville, Kentucky, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Institut Bergonie Bordeaux, France
View all 16 locations
View Trial Details
Active, Not Recruiting

Safety and Efficacy of Pembrolizumab Compared to Placebo in Resected High-risk Stage II Melanoma (MK-3475-716/KEYNOTE-716)

NCT03553836

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations
  • University of Arizona Cancer Center ( Site 0121) Tucson, Arizona, United States
  • UCSD Moores Cancer Center ( Site 0133) La Jolla, California, United States
  • The Angeles Clinic and Research Institute ( Site 0029) Los Angeles, California, United States
  • UCLA Hematology & Oncology ( Site 0130) Los Angeles, California, United States
View all 159 locations
View Trial Details

Related conditions